About Avalon Pharma Private Limited
Data last updated:
Avalon Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 February 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH1999PTC118464. Its GSTIN is 27AABCA8813F1ZU (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.14 Lakh. It is led by directors including Sudhir Harkisandas Sangani (Managing Director) and Rupa Sudhir Sangani.
Its last annual general meeting (AGM) was held on 01 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sethna Building216 Shamaldas Gandhi Marg Princess Street, Mumbai, Maharashtra, India – 400002.
As per the financials filed for FY 2026, the company reported a revenue of ₹5.1 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹37.55 Lakh (net margin 7.4%) and EBITDA of ₹61.44 Lakh (EBITDA margin 12%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 12% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website avalonpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressSethna Building216 Shamaldas Gandhi Marg Princess Street, Mumbai, Maharashtra, India – 400002
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Avalon Pharma Private Limited
The main business activity of Avalon Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Avalon Pharma Private Limited FY 2025 filings available
Avalon Pharma Private Limited reported revenue of ₹5.1 Cr (up 19% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR) of Avalon Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 19% growth in the latest year. EBITDA rose 184% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Avalon Pharma Private Limited
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹61.44 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹37.55 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Avalon Pharma Private Limited
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Avalon Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Avalon Pharma Private Limited
Avalon Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avalon Pharma Private Limited this company | ₹5.1 Cr (FY 2026) | •••• | •••• | 19.0% | •••• | Mumbai, Maharashtra, India |
| Oxygen Remedies Private Limited | ₹4.32 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Kanpur, Uttar Pradesh, India |
| Trevo India Private Limited | ₹4.32 Cr (FY 2018) | •••• | •••• | -30.0% | •••• | Hyderabad, Telangana, India |
| Apace Life Sciences Private Limited | ₹4.31 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Hubli, Karnataka, India |
| Mod Medicare Systems Private Limited | ₹4.31 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | New Delhi, Delhi, India |
| Lantr Marketing Private Limited | ₹4.31 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Mumbai, Maharashtra, India |
| Manju Enterprises Private Limited | ₹4.29 Cr (FY 2025) | •••• | •••• | 67.0% | •••• | New Delhi, Delhi, India |
| Jairam Mediserve Private Limited | ₹4.28 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Hooghly, West Bengal, India |
| Alkans Pharmaceuticals Private Limited | ₹4.27 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Lucknow, Uttar Pradesh, India |
| Azton Healthcare Private Limited | ₹4.26 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Talwade, Maharashtra, India |
| Resante Life Sciences Private Limited | ₹4.25 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Avalon Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Avalon Pharma Private Limited
Avalon Pharma Private Limited is audited by BILIMORIA MEHTA & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BILIMORIA MEHTA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Avalon Pharma Private Limited
Avalon Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhir Harkisandas Sangani | Managing Director | 22 Feb 1999 | 27 Years 7 Months | Current |
| Rupa Sudhir Sangani | Director | 22 Feb 1999 | 27 Years 7 Months | Current |
| Kunal Sudhir Sangani | Director | 02 Apr 2007 | 19 Years 6 Months | Current |
Ownership and Shareholding of Avalon Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Avalon Pharma Private Limited
Avalon Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Avalon Pharma Private Limited
Employment history and EPFO contributions of people linked to Avalon Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Avalon Pharma Private Limited
Avalon Pharma Private Limited has 3 board changes on record since 1999: 3 appointments. The latest: Kunal Sudhir Sangani was appointed as Director on 02 Apr 2007.
Credit Ratings, Litigation & Regulatory Alerts for Avalon Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Avalon Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Avalon Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Avalon Pharma Private Limited
Avalon Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCA8813F1ZU | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Avalon Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avalon Pharma Private Limited
Avalon Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 February 1999 (27+ years old) and is registered under CIN U51397MH1999PTC118464.
Avalon Pharma reported revenue of ₹5.1 Cr for FY 2026 (up 19% YoY).
Avalon Pharma has 3 current directors:
- Sudhir Harkisandas Sangani - Managing Director
- Rupa Sudhir Sangani - Director
- Kunal Sudhir Sangani - Director
Avalon Pharma reported a net profit of ₹37.55 Lakh (net margin 7.4%) and EBITDA of ₹61.44 Lakh (EBITDA margin 12%) for FY 2026, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Avalon Pharma is 10% over three years and 12% over five years. In the latest year (FY 2026) revenue rose 19%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Avalon Pharma is 27AABCA8813F1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Avalon Pharma is U51397MH1999PTC118464. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avalon Pharma was incorporated on 22 February 1999, making it 27+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Avalon Pharma by revenue are Oxygen Remedies Private Limited, Trevo India Private Limited, Apace Life Sciences Private Limited, Mod Medicare Systems Private Limited, Lantr Marketing Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Kunal Sudhir Sangani was appointed as Director on 02 Apr 2007. Rupa Sudhir Sangani was appointed as Director on 22 Feb 1999. Sudhir Harkisandas Sangani was appointed as Managing Director on 22 Feb 1999.
Avalon Pharma can be reached through the website avalonpharma.com. Its registered office is in Mumbai, Maharashtra, India.